A 68-year-old woman with hypertension (on amlodipine) and type 2 diabetes is undergoing total hip replacement under epidural anesthesia. After successful epidural catheter placement at L3–L4, 15 mL of 0.75% ropivacaine is injected. Within 3 minutes, the patient complains of dizziness, perioral numbness, and tinnitus. Blood pressure drops from 138/85 to 98/60 mmHg, heart rate increases to 128 bpm, and the patient becomes restless and confused. What is the most appropriate immediate management?

Explanation

## Recognition of Local Anesthetic Systemic Toxicity (LAST) ### Clinical Presentation The patient exhibits classic early signs of LAST: - **Neurological:** Perioral numbness, tinnitus, dizziness, restlessness, confusion - **Cardiovascular:** Hypotension (98/60), tachycardia (128 bpm) - **Temporal:** Onset within 3 minutes of epidural injection **Key Point:** LAST is a medical emergency caused by systemic absorption of local anesthetic into the bloodstream. Early recognition and immediate lipid emulsion therapy are life-saving. ### Mechanism of LAST Ropivacaine, a long-acting amide local anesthetic, blocks cardiac sodium channels and myocardial conduction, causing: 1. Initial CNS excitation (restlessness, confusion, seizure risk) 2. Cardiovascular depression (hypotension, bradycardia, arrhythmias, cardiac arrest) 3. Potential for refractory cardiac arrest if untreated **High-Yield:** Risk factors in this patient: - Age >60 years (reduced clearance) - Diabetes (altered pharmacokinetics) - High-dose ropivacaine (15 mL of 0.75% = 112.5 mg, approaching maximum recommended dose) - Epidural injection (vascular absorption possible with misplacement) ### Management Algorithm ```mermaid flowchart TD A[Suspected LAST]:::urgent --> B[Stop injection immediately]:::action B --> C[Call for help + ACLS team]:::action C --> D[100% oxygen, establish IV access]:::action D --> E[Prepare 20% lipid emulsion]:::action E --> F[Bolus: 1.5 mL/kg IV over 1 min]:::action F --> G{Seizure or cardiac instability?}:::decision G -->|Yes| H[Lipid infusion: 0.25 mL/kg/min]:::action G -->|No| I[Observe, repeat bolus q5min if needed]:::action H --> J[Supportive care + ACLS as needed]:::action I --> J J --> K[Monitor for ≥4–6 hours]:::action ``` **Mnemonic: LAST Management — LIPID** — **L**ipid emulsion 20%, **I**mmediate IV access, **P**osition supine, **I**ntubate if seizure, **D**ose: 1.5 mL/kg bolus, repeat every 5 minutes. **Clinical Pearl:** Lipid emulsion works by creating a "lipid sink" that sequesters lipophilic local anesthetics away from cardiac and neural tissue. It is the only proven specific antidote for LAST and must be given immediately — do NOT delay for other interventions. ### Why Lipid Emulsion Is Essential | Intervention | Rationale | Outcome | | --- | --- | --- | | Lipid emulsion | Sequesters local anesthetic | Reverses toxicity | | Oxygen | Corrects hypoxia | Supports cardiac function | | IV access | Enables drug administration | Necessary for resuscitation | | Atropine/ephedrine | Treats hypotension | Does NOT address root cause | | Saline bolus | Fluid resuscitation | Inadequate for LAST | | Sedation alone | Masks symptoms | Delays definitive treatment |